Encapsulated vaccines for the oral vaccination and...

Details Encapsulated vaccines for the oral vaccination and... Encapsulated vaccines for the oral vaccination and...

2011-08-16

2011-08-16

Minnifield, Nita M (Department: 1645)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Food or edible as carrier for pharmaceutical

C424S184100, C424S278100, C424S439000, C424S451000, C424S489000, C424S490000, C424S780000, C514S001200

Reexamination Certificate

active

07998502

ABSTRACT:
The invention relates to a composition comprising a pharmaceutically active agent and a bioadhesive delivery system that provides for the oral delivery of a vaccine to animals, particularly aquatic animals.

REFERENCES:
patent: 6485950 (2002-11-01), Kumar et al.
patent: 7670627 (2010-03-01), Shefer et al.
patent: 2004/0081638 (2004-04-01), Kyle
patent: 2004/0177392 (2004-09-01), Barratt et al.
patent: 2004/0224019 (2004-11-01), Shefer et al.
patent: 2006/0024404 (2006-02-01), Kyle
patent: 2006/0120999 (2006-06-01), Dhar
patent: 2006/0121468 (2006-06-01), Allnutt et al.
patent: 2006/0127453 (2006-06-01), Harel
patent: 2006/0130162 (2006-06-01), Kyle et al.
patent: 2007/0082008 (2007-04-01), Harel et al.
patent: 2007/0292952 (2007-12-01), Dhar et al.
patent: 2008/0044481 (2008-02-01), Harel
patent: 2008/0194504 (2008-08-01), Kyle
patent: 2008/0268063 (2008-10-01), Jon et al.
patent: 2009/0181363 (2009-07-01), Dhar
patent: 2009/0238845 (2009-09-01), Harel
patent: 2009/0238890 (2009-09-01), Piechocki et al.
patent: 2009/0246184 (2009-10-01), Harel et al.
patent: 2010/0143481 (2010-06-01), Shenoy et al.
patent: 2659917 (2009-09-01), None
patent: 1534307 (2005-06-01), None
patent: 2105129 (2009-09-01), None
patent: WO9531184 (1995-11-01), None
patent: WO 02/076391 (2002-10-01), None
patent: WO 03/089579 (2003-10-01), None
patent: WO03086454 (2003-10-01), None
patent: WO 03/103692 (2003-12-01), None
patent: WO 2004/043139 (2004-05-01), None
patent: WO2004043140 (2004-05-01), None
patent: WO 2005/017134 (2005-02-01), None
patent: WO 2005/115341 (2005-12-01), None
patent: WO 2006/122299 (2006-11-01), None
patent: WO2007058462 (2007-05-01), None
patent: WO 2007/067207 (2007-06-01), None
patent: WO 2007/104562 (2007-09-01), None
patent: WO 2007/117511 (2007-10-01), None
patent: WO 2008/063910 (2008-05-01), None
patent: WO 2008/076975 (2008-06-01), None
patent: WO 2008/140610 (2008-11-01), None
patent: WO 2008/154294 (2008-12-01), None
patent: WO 2010/042555 (2010-04-01), None
Friend, Advanced Drug Delivery Reviews. 2005, 57:247-265.
Benyacoub, B., Rochat, F., K.Y, S., Rochat, I., Antille, N., Cherbut, C., von der Weid, T., Schiffrin., E.J., Blum, S., 2008. Feeding a Diet Containing a Fructooligosaccharide Mix Can EnhanceSalmonellaVaccine Efficacy in Mice. J. Nutr. 138, 123-129.
Dang, J.M., Leong, K.W., 2006. Natural polymers for gene delivery and tissue engineering. Adv. Drug Deliv. Rev. 58(4), 487-499.
van der Lubben, I.M., Verhoef, J.C., Borchard, G., Junginger, H.E., 2001. Chitosan for mucosal vaccination. Advanced Drug Delivery Reviews 52 (2), 139-144.
van der Lubben, I.M., Verhoef, J.C., van Aelst, A.C., Borchard, G., Junginger, H.E., 2001. Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches. Biomaterials 22(7), 687-694.
Wu, X.S., 2004. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: Part III. Drug delivery application Artif. Cells Blood Substit. Immobil. Biotechnol 32(4), 575-591.
S. Bravo and PJ Midtlyng (2007) The Use of Fish Vaccines in the Chilean Salmon Industry 1999-2003. Aquaculture 270: 36-42.
Chopra, S., Mandi, S., Kau, r.J., Iqbal, Z., Talegaonkar, S., F.J, A., 2006. Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery. J. Pharm. Pharmacol. 58(8), 1021-1032.
Malik, D.K., Baboota, S., Ahuja, A., Hasan, S., Ali, J., 2007. Recent advances in protein and peptide drug delivery systems. . Curr. Drug Deliv. 4(2), 141-151.
Kim, T.J., Kim, K.H., Lee, J.I., 2007. Stimulation of mucosal and systemic antibody responses against recombinant transferrin-binding protein B ofActinobacillus pleuropneumoniaewith chitosan after tracheal administration in piglets. J. Vet. Med. Sci. 69(5), 535-539.
Kang, M.L., Jiang, H.L., Kang, S.G., Guo, D.D., Lee, D.Y., Cho, C.S., Yoo, H.S., 2007. Pluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery ofBordetella bronchisepticaantigens containing dermonecrotoxin. Vaccine 25(23), 4602-4610.
Davis, S.S., 2006. The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery. Vaccine 24(2), 7-10.
Siwicki, A.K. et al. “Dietary intake of immunostimulants by rainbow trout affects non-specific immunity and protection against furunculosis.” Veterinary Immunology and Immunopathology, vol. 41, No. 1-2, May 1, 1994, pp. 125-139.

Affiliated with

Also associated with

Rating

Encapsulated vaccines for the oral vaccination and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Encapsulated vaccines for the oral vaccination and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Encapsulated vaccines for the oral vaccination and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2686526